Skip to main content
Erschienen in: Virchows Archiv 2/2020

05.08.2019 | Brief Report

Sarcoma with MGANUTM1 fusion in the lung: an emerging entity

verfasst von: Taichiro Goto, Yasuhito Arai, Tatsuhiro Shibata, Toshio Oyama, Akihiko Yoshida

Erschienen in: Virchows Archiv | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

We here document a sarcoma with a recently reported MGA–NUTM1 fusion. A 49-year-old man presented with a nodule in the right lung, which grew to a giant mass in 5 years. The tumor showed uniform oval to spindle cell proliferation in a hypervascular stroma, associated with focal myxoid change and peculiar collagen deposition resembling an osteoid. The tumor showed an undifferentiated phenotype, including negativity for cytokeratin, although it was immunoreactive to BCOR and MUC4, and was initially suspected as BCOR-associated sarcoma. After complete resection, the tumor recurred in the mediastinal lymph node, and the patient died of the disease. RNA sequencing detected MGA (exon 22)–NUTM1 (exon 3), which was confirmed by reverse transcriptase-polymerase chain reaction, Sanger sequencing, fluorescence in situ hybridization, and NUT immunohistochemistry. Clinicopathological features of the present case were similar to some of the reported cases of MGA–NUTM1 sarcomas, suggesting the emergence of a distinct tumor subtype.
Literatur
1.
Zurück zum Zitat French CA (2018) NUT carcinoma: clinicopathologic features, pathogenesis, and treatment. Pathol Int 68:583–595CrossRef French CA (2018) NUT carcinoma: clinicopathologic features, pathogenesis, and treatment. Pathol Int 68:583–595CrossRef
2.
Zurück zum Zitat Le Loarer F, Pissaloux D, Watson S et al (2019) Clinicopathologic features of CIC-NUTM1 sarcomas, a new molecular variant of the family of CIC-fused sarcomas. Am J Surg Pathol 43:268–276CrossRef Le Loarer F, Pissaloux D, Watson S et al (2019) Clinicopathologic features of CIC-NUTM1 sarcomas, a new molecular variant of the family of CIC-fused sarcomas. Am J Surg Pathol 43:268–276CrossRef
3.
Zurück zum Zitat Dickson BC, Sung YS, Rosenblum MK, Reuter VE, Harb M, Wunder JS, Swanson D, Antonescu CR (2018) NUTM1 gene fusions characterize a subset of undifferentiated soft tissue and visceral tumors. Am J Surg Pathol 42:636–645CrossRef Dickson BC, Sung YS, Rosenblum MK, Reuter VE, Harb M, Wunder JS, Swanson D, Antonescu CR (2018) NUTM1 gene fusions characterize a subset of undifferentiated soft tissue and visceral tumors. Am J Surg Pathol 42:636–645CrossRef
4.
Zurück zum Zitat Diolaiti D, Dela Cruz FS, Gundem G et al (2018) A recurrent novel MGA-NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma. Cold Spring Harb Mol Case Stud 4:a003194CrossRef Diolaiti D, Dela Cruz FS, Gundem G et al (2018) A recurrent novel MGA-NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma. Cold Spring Harb Mol Case Stud 4:a003194CrossRef
5.
Zurück zum Zitat Stevens TM, Morlote D, Xiu J, Swensen J, Brandwein-Weber M, Miettinen MM, Gatalica Z, Bridge JA (2019) NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum. Mod Pathol 32:764–773CrossRef Stevens TM, Morlote D, Xiu J, Swensen J, Brandwein-Weber M, Miettinen MM, Gatalica Z, Bridge JA (2019) NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum. Mod Pathol 32:764–773CrossRef
6.
Zurück zum Zitat Tamura R, Nakaoka H, Yoshihara K, Mori Y, Yachida N, Nishikawa N, Motoyama T, Okuda S, Inoue I, Enomoto T (2018) Novel MXD4-NUTM1 fusion transcript identified in primary ovarian undifferentiated small round cell sarcoma. Genes Chromosom Cancer 57:557–563CrossRef Tamura R, Nakaoka H, Yoshihara K, Mori Y, Yachida N, Nishikawa N, Motoyama T, Okuda S, Inoue I, Enomoto T (2018) Novel MXD4-NUTM1 fusion transcript identified in primary ovarian undifferentiated small round cell sarcoma. Genes Chromosom Cancer 57:557–563CrossRef
7.
Zurück zum Zitat Mantilla JG, Ricciotti RW, Chen E, Hoch BL, Liu YJ (2019) Detecting disease-defining gene fusions in unclassified round cell sarcomas using anchored multiplex PCR/targeted RNA next-generation sequencing-molecular and clinicopathological characterization of 16 cases. Genes Chromosom Cancer Mantilla JG, Ricciotti RW, Chen E, Hoch BL, Liu YJ (2019) Detecting disease-defining gene fusions in unclassified round cell sarcomas using anchored multiplex PCR/targeted RNA next-generation sequencing-molecular and clinicopathological characterization of 16 cases. Genes Chromosom Cancer
8.
Zurück zum Zitat Taniyama TK, Nokihara H, Tsuta K, Horinouchi H, Kanda S, Fujiwara Y, Yamamoto N, Koizumi F, Yunokawa M, Tamura T (2014) Clinicopathological features in young patients treated for small-cell lung cancer: significance of immunohistological and molecular analyses. Clin Lung Cancer 15:244–247CrossRef Taniyama TK, Nokihara H, Tsuta K, Horinouchi H, Kanda S, Fujiwara Y, Yamamoto N, Koizumi F, Yunokawa M, Tamura T (2014) Clinicopathological features in young patients treated for small-cell lung cancer: significance of immunohistological and molecular analyses. Clin Lung Cancer 15:244–247CrossRef
9.
Zurück zum Zitat Schoffski P, Chawla S, Maki RG et al (2016) Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial. Lancet 387:1629–1637CrossRef Schoffski P, Chawla S, Maki RG et al (2016) Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial. Lancet 387:1629–1637CrossRef
10.
Zurück zum Zitat Kao YC, Sung YS, Zhang L, Jungbluth AA, Huang SC, Argani P, Agaram NP, Zin A, Alaggio R, Antonescu CR (2016) BCOR overexpression is a highly sensitive marker in round cell sarcomas with BCOR genetic abnormalities. Am J Surg Pathol 40:1670–1678CrossRef Kao YC, Sung YS, Zhang L, Jungbluth AA, Huang SC, Argani P, Agaram NP, Zin A, Alaggio R, Antonescu CR (2016) BCOR overexpression is a highly sensitive marker in round cell sarcomas with BCOR genetic abnormalities. Am J Surg Pathol 40:1670–1678CrossRef
11.
Zurück zum Zitat Argani P, Kao YC, Zhang L, Sung YS, Alaggio R, Swanson D, Matoso A, Dickson BC, Antonescu CR (2019) BCOR overexpression in renal malignant solitary fibrous tumors: a close mimic of clear cell sarcoma of kidney. Am J Surg Pathol 43:773–782CrossRef Argani P, Kao YC, Zhang L, Sung YS, Alaggio R, Swanson D, Matoso A, Dickson BC, Antonescu CR (2019) BCOR overexpression in renal malignant solitary fibrous tumors: a close mimic of clear cell sarcoma of kidney. Am J Surg Pathol 43:773–782CrossRef
12.
Zurück zum Zitat Doyle LA, Moller E, Dal Cin P et al (2011) MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Am J Surg Pathol 35:733–741CrossRef Doyle LA, Moller E, Dal Cin P et al (2011) MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Am J Surg Pathol 35:733–741CrossRef
13.
Zurück zum Zitat Doyle LA, Wang WL, Dal Cin P, Lopez-Terrada D, Mertens F, Lazar AJF, Fletcher CDM, Hornick JL (2012) MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement. Am J Surg Pathol 36:1444–1451CrossRef Doyle LA, Wang WL, Dal Cin P, Lopez-Terrada D, Mertens F, Lazar AJF, Fletcher CDM, Hornick JL (2012) MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement. Am J Surg Pathol 36:1444–1451CrossRef
14.
Zurück zum Zitat Amatya VJ, Kushitani K, Mawas AS et al (2017) MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma. Mod Pathol 30:672–681CrossRef Amatya VJ, Kushitani K, Mawas AS et al (2017) MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma. Mod Pathol 30:672–681CrossRef
15.
Zurück zum Zitat Cascon A, Robledo M (2012) MAX and MYC: a heritable breakup. Cancer Res 72:3119–3124CrossRef Cascon A, Robledo M (2012) MAX and MYC: a heritable breakup. Cancer Res 72:3119–3124CrossRef
Metadaten
Titel
Sarcoma with MGA–NUTM1 fusion in the lung: an emerging entity
verfasst von
Taichiro Goto
Yasuhito Arai
Tatsuhiro Shibata
Toshio Oyama
Akihiko Yoshida
Publikationsdatum
05.08.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 2/2020
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-019-02623-8

Weitere Artikel der Ausgabe 2/2020

Virchows Archiv 2/2020 Zur Ausgabe

Neu im Fachgebiet Pathologie